How a novel genomic analysis leveraged whole-exome and RNA sequencing to save the life of an elderly patient
July 16, 2024
An 81-year-old former minor league baseball player with a history of cancer arrived at the emergency department with a fractured forearm and leg pain after a fall at home.
Welcome to the Inaugural 'Bridge 2AI' Voice Summer School Class!
July 11, 2024
The EIPM is thrilled to welcome the inaugural 'Bridge 2AI' Voice Summer School Class!
The project Voice as a Biomarker of Health is one of several recently funded projects of the NIH Common Fund’s Bridge2AI program, which is designed to use AI to tackle complex biomedical challenges.
EIPM's Second Quarter External Newsletter
July 1, 2024
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our second quarterly external newsletter of 2024!
The Sounds of Science
June 24, 2024
Sound as Biomarker
Dr. Anaïs Rameau is the granddaughter of a poet who lost his voice to cancer. Though he died when she was young, that spiritual connection steered Dr. Rameau into otolaryngology, where she now helps patients with difficulty speaking, swallowing or breathing.
Ultrasensitive Liquid Biopsy Tech Spots Cancer Earlier than Standard Methods
June 14, 2024
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center (NYGC) and Memorial Sloan Kettering Cancer Center.
EIPM Director's Memo
June 12, 2024
June 2024 EIPM Director's Memo
Dear Members of the Englander Institute,
Thank you all for a very productive past six weeks!
May 2024 EIPM Director's Monthly Newsletter
May 10, 2024
Dear Members of the Englander Institute,
Thank you all for a very productive April!
GoT-ChA: A New Tool for Detailing How Gene Mutations Affect Cells
May 9, 2024
A team co-led by researchers at Weill Cornell Medicine and the New York Genome Center has developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA. These structural changes, which alter patterns of gene activity in a cell, are known as epigenetic changes and can lead to malignancy.
Melanoma Monday: From Early Detection to Cutting-Edge Treatments
May 6, 2024
Melanoma, the deadliest form of skin cancer, is on the rise. But there's a silver lining as this increase might be partly due to earlier detection. The use of Dermoscopy, a handheld device which allows closer surveillance of the organization of a mole or lesion, has greatly facilitated in detection of melanomas and moles that are dysplastic/or atypical. This device allows doctors to see the intricate structure of moles, helping identify suspicious ones.